Get the word out. Share this event with your colleagues. Click to post.

Diversity in Clinical Trials

Virtual
Diversity in Clinical Trials
Tuesday, November 29, 2022 | 6:30 p.m. - 7:15 p.m.
Online registration is now closed. Please call Customer relations at 212 382 6663 to register or for assistance.
Program Fee:
Free for Members and Non-Lawyers | $15 Non-Members
Non-Lawyers please call Customer Relations at 212-382-6663 to register. 

Please Note: A final confirmation containing the Zoom link and Access Code to join the event will be sent to ALL registrants 2 hours prior to the start of the event.  

Description:
Historically there has been a lack of diversity with respect to participation in clinical trials of new drugs. This underrepresentation can mask health and safety effects of a drug on diverse populations. The panel of speakers will address the historical lack of diversity in clinical trials as well as recommendations for promoting diversity in clinical trials, including a draft Guidance issued by the FDA in 2022.

Moderator:
Marta E. Delsignore, Goodwin Procter LLP

Speakers:
Dr. Alex Helman, Senior Program Officer, Committee on Women in Science, Engineering, and Medicine, Policy and Global Affairs Division, National Academies of Sciences, Engineering, and Medicine
Sharon H Hrynkow PhD, Founder and Managing Partner, Global Health Consulting LLC
Elizabeth Mulkey, Goodwin Procter LLP

Sponsoring Committee:
Science & the Law, Irene Byhovsky, Chair

Co-Sponsoring Committees:
Bioethical Issues, Anne Zimmerman, Chair
Diversity, Equity, and Inclusion, Brittani McDonald and David Sarnoff, Co-Chairs
Health Law, Heather A. Hatcher, Chair


Where
Online Event

Please Sign In to Register